![]() |
市场调查报告书
商品编码
1620607
免疫保健补充剂市场机会、成长动力、行业趋势分析和预测 2024 - 2032Immune Health Supplements Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032 |
2023 年,全球免疫健康补充剂市场估值为 253 亿美元,预计 2024 年至 2032 年将以 9.8% 的年复合成长率(CAGR) 增长。矿物质、草药和其他成分,旨在增强免疫功能,减少疾病的严重程度和持续时间,并促进整体健康。该市场成长的主要动力是慢性病盛行率的增加,导致对免疫保健补充剂的需求增加。随着慢性病患者寻求增强免疫系统的方法,市场不断扩大。此外,健康意识的增强,尤其是老龄化人口的健康意识的增强,进一步推动了这项需求。
老年人更容易出现免疫力下降的情况,因此越来越多地转向补充剂作为预防性健康措施。补充剂配方的创新也有助于市场成长。这些进步可以提供更有针对性和更有效的免疫支持,将免疫保健补充剂定位为主动医疗保健策略的重要组成部分。就产品类型而言,市场分为维生素、矿物质补充剂、草药补充剂、益生菌、氨基酸、omega-3 脂肪酸和电解质等类别。
维生素领域在 2023 年价值达 73 亿美元,在市场中占据主导地位,预计将继续成长。众所周知,必需维生素 A、C、D 和 E 在支持免疫功能方面发挥着至关重要的作用,因此备受追捧。从剂型来看,市场分为胶囊剂、锭剂、粉末剂、液体剂等。胶囊到 2023 年将占据 34.2% 的市场份额,预计将大幅成长。
市场范围 | |
---|---|
开始年份 | 2023年 |
预测年份 | 2024-2032 |
起始值 | 253亿美元 |
预测值 | 580 亿美元 |
复合年增长率 | 9.8% |
它们提供更好的生物利用度,使营养物质更快被吸收到血液中。某些胶囊配方也设计用于延迟或定向释放,确保活性成分在消化系统内的最佳点被吸收。从地区来看,北美预计将主导免疫保健品市场,预计到 2032 年该地区将达到 232 亿美元。糖尿病、癌症和自体免疫疾病等慢性病的高发生率是推动该地区需求的重要因素。
监管监督确保这些产品符合安全和标籤标准,进一步增强消费者对现有补充剂的功效和品质的信心。
The Global Immune Health Supplements Market was valued at USD 25.3 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2032. These supplements, designed to support the immune system, include a range of vitamins, minerals, herbs, and other ingredients that aim to enhance immune function, reduce the severity and duration of illness, and promote overall health. A major driver behind this market's growth is the increasing prevalence of chronic diseases, leading to greater demand for immune health supplements. As individuals with chronic conditions seek ways to strengthen their immune systems, the market continues to expand. Additionally, growing health awareness, particularly among aging populations, further fuels this demand.
The elderly, being more prone to immune decline, are increasingly turning to supplements as a preventive health measure. Innovations in supplement formulations are also contributing to market growth. These advancements allow for more targeted and effective immune support, positioning immune health supplements as essential components of proactive healthcare strategies. In terms of product types, the market is segmented into categories like vitamins, mineral supplements, herbal supplements, probiotics, amino acids, omega-3 fatty acids, and electrolytes.
The vitamins segment, valued at USD 7.3 billion in 2023, dominated the market and is expected to continue growing. Essential vitamins like A, C, D, and E are known to play a crucial role in supporting immune function, making them highly sought-after. When looking at formulations, the market is categorized into capsules, tablets, powder, liquid, and others. Capsules, which held a 34.2% market share in 2023, are anticipated to see substantial growth.
Market Scope | |
---|---|
Start Year | 2023 |
Forecast Year | 2024-2032 |
Start Value | $25.3 Billion |
Forecast Value | $58 Billion |
CAGR | 9.8% |
They offer better bioavailability, allowing nutrients to be absorbed more quickly into the bloodstream. Certain capsule formulations are also designed for delayed or targeted release, ensuring that the active ingredients are absorbed at optimal points within the digestive system. Regionally, North America is expected to dominate the immune health supplements market, with the region forecasted to reach USD 23.2 billion by 2032. The U.S. led the North American market in 2023, generating revenue of USD 9.4 billion. The high incidence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, is a significant factor driving demand in the region.
Regulatory oversight ensures that these products meet safety and labeling standards, further boosting consumer confidence in the efficacy and quality of the supplements available.